Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Sexually Transmitted Diseases

  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 38 articles:
HTML format

Single Articles

    October 2018
  1. MENARD A, Meddeb L, Conrath J, Charrel RN, et al
    Ocular syphilis, an old adversary is back in the old world too!
    AIDS. 2018;32:2433-2434.

  2. ALDERSLEY J, Lorenz DR, Misra V, Uno H, et al
    Increased risk of anal squamous cell carcinoma in HIV-positive men with prior HBV infection.
    AIDS. 2018 Oct 16. doi: 10.1097/QAD.0000000000002059.
    PubMed     Abstract available

  3. FORD ES, Magaret AS, Spak CW, Selke S, et al
    Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002002.
    PubMed     Abstract available

    September 2018
  4. KELLER MJ, Burk RD, Massad LS, Eltoum IE, et al
    Racial differences in HPV types amongst US women with HIV and cervical precancer.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002005.
    PubMed     Abstract available

    We need to consider collateral damage to resistomes when we decide how frequently to screen for chlamydia/gonorrhoea in PrEP cohorts.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002020.
    PubMed     Abstract available

    August 2018
  6. ANTONIO MB, Cuba GT, Vasconcelos RP, Alves APPS, et al
    Natural experiment of syphilis treatment with doxycycline or benzathine penicillin in HIV-infected patients.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001975.
    PubMed     Abstract available

    July 2018
  7. VERMUND SH, Kelley KF
    Impact of HIV on human papilloma virus-mediated cervical disease progression.
    AIDS. 2018;32:1715-1717.

  8. LIU Y, Blakely M, Sigel K, Thin TH, et al
    Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001957.
    PubMed     Abstract available

  9. CLIFFORD GM, Siproudhis L, Piroth L, Poizot-Martin I, et al
    Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001947.
    PubMed     Abstract available

    June 2018
  10. KOUYOUMJIAN SP, Heijnen M, Chaabna K, Mumtaz GR, et al
    Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence.
    AIDS. 2018;32:1343-1352.
    PubMed     Abstract available

    February 2018
  11. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    PubMed     Abstract available

  12. WOOD S, Ratcliffe S, Gowda C, Lee S, et al
    Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001772.
    PubMed     Abstract available

    January 2018
  13. LIU G, Sharma M, Tan N, Barnabas R, et al
    HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.
    AIDS. 2018 Jan 24. doi: 10.1097/QAD.0000000000001765.
    PubMed     Abstract available

  14. KOJIMA N, Klausner JD
    Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection.
    AIDS. 2018;32:272-275.

    December 2017
  15. NGUYEN VK, Greenwald ZR, Trottier H, Cadieux M, et al
    Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001718.
    PubMed     Abstract available

    August 2017
  16. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
    AIDS. 2017;31:1859-1866.
    PubMed     Abstract available

    July 2017
  17. BURGOS J, Hernandez-Losa J, Landolfi S, Guelar A, et al
    The role of oncogenic HPV determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001605.
    PubMed     Abstract available

  18. VIEIRA VA, Avelino-Silva VI, Cerqueira NB, Costa DA, et al
    Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T cell activation.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001580.
    PubMed     Abstract available

  19. VAN ZUMMEREN M, Kremer WW, Van Aardt MC, Breytenbach E, et al
    Selection of women at risk for cervical cancer in an HIV-infected SOUTH AFRICAN population.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001583.
    PubMed     Abstract available

  20. STONER MCD, Pettifor A, Edwards JK, Aiello AE, et al
    The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001584.
    PubMed     Abstract available

    May 2017
  21. OMORI R, Abu-Raddad LJ
    Sexual network drivers of HIV and herpes simplex virus type 2 (HSV-2) transmission: a comparative mathematical modeling analysis.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001542.
    PubMed     Abstract available

  22. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in MSM.
    AIDS. 2017;31:1169-1180.
    PubMed     Abstract available

    March 2017
  23. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    PubMed     Abstract available

  24. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    PubMed     Abstract available

  25. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    PubMed     Abstract available

    February 2017
  26. COMBES JD, Clifford GM, Egger M, Cavassini M, et al
    Human papillomavirus antibody response following HAART initiation among MSM.
    AIDS. 2017;31:561-569.
    PubMed     Abstract available

    January 2017
  27. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    PubMed     Abstract available

  28. MAKAROVA N, Henning T, Taylor A, Dinh C, et al
    Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001389.
    PubMed     Abstract available

  29. STREECK H, Verheyen J, Storim J, Dittmer U, et al
    Pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:176-177.

    December 2016
  30. SERRANO-VILLAR S, Vasquez-Dominguez E, Perez-Molina JA, Sainz T, et al
    HIV, HPV and microbiota: partners in crime?
    AIDS. 2016.
    PubMed     Abstract available

    November 2016
  31. ORANG'O O, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.
    AIDS. 2016.
    PubMed     Abstract available

    October 2016
  32. KELLY HA, Sawadogo B, Chikandiwa A, Segondy M, et al
    Epidemiology of High-risk Human Papillomavirus and Cervical Lesions in African women living with HIV/AIDS: Effect of Anti-Retroviral Therapy.
    AIDS. 2016.
    PubMed     Abstract available

    January 2016
  33. KONOPNICKI D, Manigart Y, Gilles C, Barlow P, et al
    High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
    AIDS. 2016;30:425-433.
    PubMed     Abstract available

  34. SENDAGORTA E, Bernardino JI, Alvarez-Gallego M, Feito M, et al
    Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
    AIDS. 2016;30:75-82.
    PubMed     Abstract available

  35. MOOIJ SH, van Santen DK, Geskus RB, van der Sande MA, et al
    The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.
    AIDS. 2016;30:121-32.
    PubMed     Abstract available

  36. COGHILL AE, Shiels MS, Rycroft RK, Copeland G, et al
    Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
    AIDS. 2016;30:105-12.
    PubMed     Abstract available

  37. GESKUS RB, Gonzalez C, Torres M, Del Romero J, et al
    Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    AIDS. 2016;30:37-44.
    PubMed     Abstract available

  38. PARK LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, et al
    Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.
    AIDS. 2016;30:273-91.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.